Skip to content
CAR T Cell Therapy for Refractory and Early Relapsed DLBCL - Video Series
We hope you found the content valuable; your feedback is very important to us and we appreciate you taking the time to complete this evaluation form.
1.
Profession
Physician
Nurse
Pharmacist
Social worker or case manager
Other (please specify)
2.
How relevant was this learning program to your practice/role?
Not applicable
Not at all relevant
Slightly relevant
Moderately relevant
Very relevant
Extremely relevant
3.
Overall, how satisfied are you with the quality of the learning content?
Not applicable
Not at all satisfied
Slightly satisfied
Moderately satisfied
Very satisfied
Extremely satisfied
4.
How satisfied are you that the learning objectives were achieved?
Learning objectives for this program included:
1. Review the pivotal data that supports the use of CAR T cell therapy for patients with refractory or early relapsed LBCL after frontline therapy
2. Discuss the indications and eligibility criteria for patients with relapsed or refractory LBCL to be treated with CAR T cell therapy
3. Understand the difference in referral and treatment pathways for CAR T cell therapy compared to autologous stem cell transplant
4. Discuss responsibilities of referring and treating health care teams when preparing patients for CAR T cell therapy and following treatment
Not applicable
Not at all satisfied
Slightly satisfied
Moderately satisfied
Very satisfied
Extremely satisfied
5.
How will the learning content support your practice?
My current practice has been reinforced by this learning content
I plan to use the new concepts learned in this program in my practice
I may improve my practice, but I need additional information to support this learning content
Not applicable
If you selected “I may improve my practice...”, please describe what additional information is needed to support this learning content.
